InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,302.03
(
0.65%
)
US TECH 100
18,334.60
(
1.04%
)
Dow Jones
39,139.37
(
0.19%
)
Brent Oil
82.03
(
0.89%
)
Bitcoin
68,451.04
(
0.78%
)
Post# of 251930
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

AlpineBV_Miller

Send PM Follow Ignore
Followers 56
Posts 1150
Boards Moderated 0
Alias Born 11/12/2005

AlpineBV_Miller

Re: DewDiligence post# 87219

Wednesday, 12/09/2009 6:27:01 PM

Wednesday, December 09, 2009 6:27:01 PM

Post# of 251930
That's good news, then. I'll look forward to seeing Ratain at ASCO and seeing what he has to say about the development. I admit that still seems high to me, but the data are the data.

I would expect success rates in Phase III to start rising by mid-10s as a result.

Next up, smoother approval path and more sponsor acceptance for trials with target screening.

Unless otherwise indicated, this is the personal viewpoint of David Miller and not necessarily that of Biotech Stock Research, LLC

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up